SIC
HAE icon

Schwartz Investment Counsel’s Haemonetics HAE Stock Holding History

Schwartz Investment Counsel’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-65,000
Closed -$5.21M – 135
2025
Q4 		$5.21M Sell
65,000
-72,250
-53% -$4.85M 0.18% 82
2025
Q3 		$6.69M Sell
137,250
-235,250
-63% -$14.6M 0.22% 78
2025
Q2 		$27.8M Sell
372,500
-2,000
-0.5% -$132K 0.92% 42
2025
Q1 		$23.8M Buy
374,500
+223,500
+148% +$15.2M 0.82% 40
2024
Q4 		$11.8M Hold
151,000
– – 0.42% 63
2024
Q3 		$12.1M Hold
151,000
– – 0.43% 65
2024
Q2 		$12.5M Hold
151,000
– – 0.46% 62
2024
Q1 		$12.9M Buy
151,000
+32,000
+27% +$2.51M 0.47% 57
2023
Q4 		$10.2M Hold
119,000
– – 0.4% 68
2023
Q3 		$10.7M Sell
119,000
-40,000
-25% -$3.57M 0.46% 64
2023
Q2 		$13.5M Hold
159,000
– – 0.57% 50
2023
Q1 		$13.2M Sell
159,000
-25,000
-14% -$2.02M 0.58% 50
2022
Q4 		$14.5M Hold
184,000
– – 0.66% 47
2022
Q3 		$13.6M Sell
184,000
-5,000
-3% -$359K 0.7% 44
2022
Q2 		$12.3M Hold
189,000
– – 0.6% 47
2022
Q1 		$11.9M Buy
189,000
+51,000
+37% +$2.77M 0.5% 51
2021
Q4 		$7.32M Buy
138,000
+28,000
+25% +$1.71M 0.28% 62
2021
Q3 		$7.76M Buy
110,000
+20,000
+22% +$1.26M 0.32% 58
2021
Q2 		$6M Buy
90,000
+30,000
+50% +$2.12M 0.24% 69
2021
Q1 		$6.66M Hold
60,000
– – 0.29% 59
2020
Q4 		$7.13M Buy
60,000
+10,000
+20% +$1.08M 0.32% 58
2020
Q3 		$4.36M Buy
50,000
+25,000
+100% +$2.18M 0.22% 66
2020
Q2 		$2.24M Buy
+25,000
New +$2.53M 0.12% 77

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schwartz Investment Counsel's HAE Position: Q1 2026 in Review

Schwartz Investment Counsel sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 65,000 shares — an estimated $5.21M sold.

Schwartz Investment Counsel first reported a position in HAE in Q2 2020 and held it in 23 quarters. The position peaked at $27.8M in Q2 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Schwartz Investment Counsel reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Schwartz Investment Counsel sold 65,000 Haemonetics shares in Q1 2026, an estimated $5.21M.
  • Schwartz Investment Counsel first reported a position in Haemonetics in Q2 2020 and held it in 23 quarters.
  • Schwartz Investment Counsel's Haemonetics position peaked at $27.8M in Q2 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Schwartz Investment Counsel's 13F filing for Q1 2026, filed 4 May 2026.